for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

DiaMedica Therapeutics Inc

DMAC.O

Latest Trade

--

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

--

 - 

--

As of on the NASDAQ ∙ Minimum 15 minute delay

Officers & Directors

NameAgePositionAppointed
Richard D. Pilnik
Independent Chairman of the Board
57Independent Chairman of the Board2014
Rick Pauls
President, Chief Executive Officer, Director
--President, Chief Executive Officer, Director2014
Scott Kellen
Chief Financial Officer, Corporate Secretary
51Chief Financial Officer, Corporate Secretary2018
Sydney A. Gilman
Vice President - Regulatory Affairs
--Vice President - Regulatory Affairs2019
Paul Papi
Vice President - Business Development
--Vice President - Business Development2016
Harry W. Alcorn
Director
57Director2018
James T. Parsons
Director
--Director2018
Jerry Xiao
Director
--Director2016
Michael Giuffre
Independent Director
--Independent Director2010

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up